skip to Main Content

Board of Directors

Through this evolution in our structure, Fred Hutchinson Cancer Center also welcomes a new Board of Directors, an impressive roster of leaders from across diverse backgrounds and experiences to help guide our strategic vision for the future of cancer care and research in the Pacific Northwest and beyond.

Kathy Surace-Smith, Chair

Kathy Surace-Smith is currently senior vice president and general counsel of NanoString Technologies in Seattle, where she manages the company’s legal, human resources and regulatory functions. This NASDAQ-listed company develops, manufactures and sells life-sciences research tools and molecular diagnostics. She has over 30 years of experience working in high- growth private and public companies. Surace-Smith is also a member of the board of trustees of Columbia University and chair of the board’s student affairs committee. She is also active in the Seattle Metropolitan Chamber of Commerce as a member of its policy leadership group. Surace-Smith was honored by the Puget Sound Business Journal as a 2018 Woman of Influence. She received her bachelor’s degree from Princeton University and her law degree from Columbia Law School.

Kristianne "Kristi" Blake

Kristianne Blake was president of the accounting firm of Kristianne Gates Blake, P.S. for 34 years, and she continues to provide tax and financial planning services for select clients. Blake was a certified public accountant for 30 years and worked for 12 years for an international accounting firm. She has served for more than 20 years on various boards of public companies and registered investment companies, including service as a board chair, audit committee chair and governance committee member. She is currently audit committee chair for the Russell Investment Company and the Russell Investment Funds, and she is the lead director of the board of Avista Corp. Blake was a regent at the University of Washington for 12 years. She has also served on many nonprofit and economic development boards in the Spokane community.

Sean Boyle

Sean Boyle is chief operating officer of Wildlife Studios, a global mobile gaming company. Previously, Boyle served as vice president of finance at Amazon, chief financial officer of Amazon Web Services and chief financial officer of Apptio, a software company based in Bellevue, Washington, that develops technology business-management applications. He also has held various financial leadership positions at Ford Motor Company. Boyle earned a bachelor’s in commerce and finance and a Master of Business Administration from the University of Windsor. He serves as treasurer on the board of Rainier Prep, a charter school dedicated to transforming educational outcomes for low-income students of color and immigrant students. He is also a member of the board of directors for Splunk, serving as the audit chair.

Lisa Brandenburg

Lisa Brandenburg is president of UW Medicine Hospitals & Clinics and vice president for medical affairs at the University of Washington. Prior to rejoining the UW, she led the academic medical center and pediatric health practice at IBM’s Simpler Consulting and served as president of Seattle Children’s. Earlier, she served as chief operating officer and interim executive director of the University of Washington Medical Center and played a key role in the formation of Seattle Cancer Care Alliance. Brandenburg is a national expert on the use of lean methodology to redesign health care from the perspective of the customer to improve outcomes and reduce cost. She holds a Master of Business Administration with emphasis in finance, and a master’s in public health from the University of California, Berkeley.

Nancy Davidson, M.D.

Dr. Nancy Davidson is the executive vice president and executive director for clinical affairs and director of the Clinical Research Division at Fred Hutch. She holds the Raisbeck Endowed Chair for Collaborative Research. She also heads the Division of Medical Oncology at the University of Washington School of Medicine and served as president and executive director of Seattle Cancer Care Alliance. Davidson, a breast cancer oncologist, has built a worldwide reputation for her expertise and leadership in this field, for her research teasing out the role of hormones in breast cancer growth, and for her impact on the development of new standards of care. She is past president of the American Society of Clinical Oncology and the American Association of Cancer Research. She has been elected to the National Academy of Medicine and the American Academy of Arts and Sciences.

Stephen Graham

Stephen Graham practiced corporate and securities law for several decades as a partner at the major law firms of Perkins Coie LLP, Orrick LLP and Fenwick & West LLP until his retirement from the practice in 2022. Currently, he is chair of the board of directors of Washington Federal Bank, the largest bank headquartered in Washington. He also serves on the board of directors of the Institute for Systems Biology and the national board of Friends of the Children, where he is vice chair. In 2019, Graham was appointed to the Securities and Exchange Commission’s Advisory Committee on Small Business Capital Formation and co-chaired the Securities and Exchange Commission’s Advisory Committee on Small and Emerging Companies from 2011 to 2017. He received his J.D. from Yale Law School.

Joanne Harrell

Joanne Harrell is the retired senior director of USA artificial intelligence, sustainability and market development strategy at Microsoft Corp., where she had worked since 2001. Harrell’s extensive work history encompasses executive roles within the high-tech, telecommunications and nonprofit sectors. She is a former Conference Board/Brookings Institution Congressional Fellow and has completed marketing management programs at Columbia University and Stanford University. She has also completed the Stanford Advanced Management Program and a nonprofit management program at Harvard Business School. She holds a bachelor’s degree and a Master of Business Administration from the University of Washington. A regent for the UW since 2009, Harrell served as board chair in 2012-2013, and as founding chair of the Board of Regents Diversity, Equity and Inclusion Advisory Committee. She also chairs the board of Equal Opportunity Schools and is a director for both HomeStreet and HomeStreet Bank.

Jeremy Jaech

Jeremy Jaech is a technology and software entrepreneur. Currently, he serves as managing partner for Harmony Meadows LLC. Through December 2015, he was CEO of SNUPI Technologies, which uses technology to deliver sensors and web services for home hazards, conditions and threats. Previously, he co-founded Aldus, which invented desktop publishing through its PageMaker software. He then led the team that founded Visio, which brought engineering drawing to the masses. He led the founding team at Trumba, an online calendaring and event registration company, and subsequently served as CEO of Verdiem, a company in enterprise PC energy management. Jaech is a member of the University of Washington Board of Regents. He earned a Bachelor of Arts degree in mathematics in 1977 and a Master of Science in computer science in 1980 from the UW.

Thomas (Tom) Lynch, M.D.

Dr. Thomas J. Lynch Jr. is a world-renowned scientist, highly respected oncologist and successful leader of National Cancer Institute-Designated Comprehensive Cancer Centers. As president and director of Fred Hutch and holder of the Raisbeck Endowed Chair, Lynch sets the strategic direction of the center, oversees centerwide initiatives and represents the Hutch’s interests to major partners and governmental bodies. He directs the Fred Hutch/University of Washington Cancer Consortium and is principal investigator of its Cancer Center Support Grant. Before becoming the Hutch’s sixth president in February 2020, Lynch was most recently chief scientific officer of Bristol Myers Squibb. Previously, he held leadership roles as CEO of Massachusetts General Physicians Organization, director of Yale Cancer Center, physician-in-chief at Yale’s Smilow Cancer Hospital, chief of hematology-oncology at Massachusetts General Hospital and professor of medicine at Harvard Medical School.

Leigh Morgan

Leigh Morgan is chief strategy and operating officer for Nia Tero, a global social enterprise. She is a key architect of the firm’s growth, including strategy, finance, infrastructure and impact investments programs, communications, operations and governance. Morgan previously served as chief operating officer of the Bill & Melinda Gates Foundation, where she oversaw a broad portfolio including human resources, IT, information security, facilities and culture. Her previous leadership roles include serving as associate chancellor at the University of California, San Francisco, vice president and global head of human resources (product development) at Genentech, and principal organization development consultant at GlaxoSmithKline. She is a member of the Council on Foreign Relations and received a master’s degree in organization development from American University, a bachelor’s degree in religion from Duke University and an honorary doctorate from the Asian University for Women in Bangladesh.

Julie Nordstrom

Julie Nordstrom is a community volunteer, a member of the UW Medicine advisory board, and a member of the board of the Institute for Health Metrics and Evaluation. She is former chair of the UW Medicine board and former chair of the University of Washington Medical Center board, and she was the founding co-chair of the UW Department of Global Health leadership council. Nordstrom is also a trustee for Save the Children US. Nordstrom has a bachelor’s degree from UW and a law degree from Seattle University.

Eduardo Peñalver

Eduardo Peñalver is Seattle University’s 22nd president. Previously, Peñalver served as the dean of Cornell Law School from 2014 to 2021. He is a Rhodes scholar and a professor of law who clerked for former U.S. Supreme Court Justice John Paul Stevens. Peñalver received his bachelor’s from Cornell’s College of Arts & Sciences in 1994 and his law degree from Yale Law School in 1999. As a Rhodes scholar, he received his Master of Arts in philosophy and theology at Oriel College, Oxford. Peñalver has also held faculty appointments at Fordham Law School and the University of Chicago, where he was the John P. Wilson Professor of Law. He has also been a visiting professor at Harvard and Yale law schools.

Paul Ramsey, M.D.

Dr. Paul G. Ramsey is the CEO of UW Medicine, executive vice president for medical affairs and dean of the School of Medicine at the University of Washington. He has served as the senior executive leader of UW Medicine since June 1997. Ramsey graduated from Harvard College in 1971 with honors in biochemistry and received his M.D. from Harvard Medical School in 1975. Following completion of residency training in internal medicine at Massachusetts General Hospital, he came to the UW in 1978. He served as acting chair and then chair of the UW Department of Medicine from 1990 to 1997 when he was appointed to his current administrative leadership position. Ramsey was the first holder of the Robert G. Petersdorf Endowed Chair in Medicine in 1995. He received the John P. Hubbard Award from the National Board of Medical Examiners in 1999 in recognition of his research contributions in the field of evaluation, and he is an elected member of the National Academy of Medicine.

Back To Top